Intermountain Health

Salt Lake City, Utah 84157

7 studies enrolling now · 10 studies all time

What they study most

Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma, Advanced Solid Tumor, CCNE1 Amplification, Chronic Graft-Versus-Host Disease (cGVHD), Endometrial Diseases, Endometrial Neoplasms, Gastric Cancer, Heart Valve Diseases, Hepatocellular Carcinoma, Hormone Receptor Negative Breast Carcinoma

Studies at this site

• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) — Recruiting now
• Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study — Recruiting now
• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. — Recruiting now
• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus — Recruiting now
• EFS of the DUO System for Tricuspid Regurgitation — Recruiting now
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — Recruiting now
• Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study — Recruiting now
• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) — Recruiting now
• TheraSphere With Durvalumab and Tremelimumab for HCC — Running, not enrolling
• Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro — Status unconfirmed